March 26, 2026

AI Use in Cancer Diagnosis, Prognosis, and Treatment: Are We There Yet?

The promise of artificial intelligence (AI) technologies to provide highly personalized oncology care for patients and improve outcomes has been decades in the making. In a 1987 editorial in The New E...

The ASCO Post

March 26, 2026

Obesity’s Cancer Role Underestimated

A proposed framework highlights potential sources of bias in current estimates

Conexiant

March 26, 2026

Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference

Clinical researchers from Roswell Park Comprehensive Cancer Center are among the experts invited to share insights and clinical best practices at the National Comprehensive Cancer Network (NCCN) 2026 Annual Conference March 27-29 in Orlando, Florida.

Roswell Park Comprehensive Cancer Center

March 24, 2026

Low-Dose PFAS Exposure Alters Cellular Metabolism 

Cell culture model reveals lipid remodeling and oxidative stress following prolonged PFAS exposure 

The Analytical Scientist

March 24, 2026

Stanford Names Leader for Drug Development and Precision Oncology

Vivek Subbiah, MD, has been appointed as the inaugural associate director for drug development and precision oncology at the Stanford Cancer Institute, with a planned start date in spring 2026. In thi...

The ASCO Post

March 24, 2026

HER2CLIMB-05 Study: Tucatinib Enhances Progression-Free Survival as First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

The addition of the selective HER2 inhibitor tucatinib to trastuzumab and pertuzumab as first-line maintenance therapy significantly prolonged investigator-assessed progression-free survival in patien...

The ASCO Post

March 24, 2026

How the Outlook on Fertility Preservation for Patients With Cancer Is Improving

Each year in the United States, about 90,000 adolescents and young adults (AYAs), ages 15 to 39, are diagnosed with cancer,1 and they are immediately faced with myriad challenges and disruptions in th...

The ASCO Post

March 23, 2026

Machine Learning Enables Real-Time Bioprocess Optimization

An integrated machine learning framework adapts culture conditions during long perfusion runs

The Medicine Maker

March 19, 2026

Hoth Applies AI in Development of Candidate for KIT-Driven Cancers

Preclinical results and AI integration support progress toward regulatory submission

The Medicine Maker

March 17, 2026

Women More Likely to Survive Cancer—But Suffer More Severe Side Effects

Female patients with cancer had a 21% lower risk of death compared with male patients, yet a 12% higher risk of severe toxicities, according to results from an international study.

The ASCO Post